• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年医疗保险人群中分化型甲状腺癌的归因成本。

Attributable costs of differentiated thyroid cancer in the elderly Medicare population.

机构信息

Division of Outcomes Research and Quality, Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA; Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA.

出版信息

Surgery. 2013 Dec;154(6):1363-9; discussion 1369-70. doi: 10.1016/j.surg.2013.06.042. Epub 2013 Aug 22.

DOI:10.1016/j.surg.2013.06.042
PMID:23973115
Abstract

BACKGROUND

Little is known about costs associated with differentiated thyroid cancer (DTC) and follow-up care. This study used data from the Surveillance Epidemiology and End Results (SEER) database to examine cumulative costs attributable to disease stage and treatment options of DTC in elderly patients over 5 years.

METHODS

We identified 2,823 patients aged >65 years with DTC and 5,646 noncancer comparison cases from SEER Medicare data between 1995 and 2005. Cumulative costs were obtained by estimating average costs/patient in each month up to 60 months after diagnosis. We performed multivariate analyses of costs by fitting each monthly cost to linear models, controlling for demographics and comorbidities. Marginal effects of covariates were obtained by summing coefficients over 60 months.

RESULTS

Cumulative costs were $17,669/patient the first year and $48,989/patient 5 years after diagnosis. Regional disease was associated with higher costs at 1 year ($9,578) and 5 years ($8,902). Distant disease was associated with 1-year costs of $28,447 and 5-year costs of $20,103. Patients undergoing surgery and radiation had a decrease in cost of $722 at 5 years.

CONCLUSION

DTC in the elderly is associated with significant economic burden largely attributable to patient demographics, stage of disease, and treatment modalities.

摘要

背景

关于分化型甲状腺癌(DTC)及其随访护理相关的费用知之甚少。本研究利用监测、流行病学和最终结果(SEER)数据库的数据,考察了 5 年内老年患者疾病分期和治疗选择与 DTC 相关的累计成本。

方法

我们从 1995 年至 2005 年 SEER 医疗保险数据中确定了 2823 名年龄>65 岁的 DTC 患者和 5646 名非癌症对照病例。通过估计每个月每个患者的平均费用,获得了 60 个月后诊断的累积成本。我们通过将每个月的成本拟合到线性模型中,控制人口统计学和合并症,对成本进行了多变量分析。通过在 60 个月内对协变量的系数求和,获得了协变量的边际效应。

结果

第一年患者的累积费用为 17669 美元/人,第五年为 48989 美元/人。局部疾病在第 1 年(9578 美元)和第 5 年(8902 美元)与更高的费用相关。远处疾病与第 1 年的费用 28447 美元和第 5 年的费用 20103 美元相关。接受手术和放疗的患者在第 5 年的费用减少了 722 美元。

结论

老年人的 DTC 与重大的经济负担相关,主要归因于患者的人口统计学、疾病分期和治疗方式。

相似文献

1
Attributable costs of differentiated thyroid cancer in the elderly Medicare population.老年医疗保险人群中分化型甲状腺癌的归因成本。
Surgery. 2013 Dec;154(6):1363-9; discussion 1369-70. doi: 10.1016/j.surg.2013.06.042. Epub 2013 Aug 22.
2
Determinants of medicare all-cause costs among elderly patients with renal cell carcinoma.老年肾细胞癌患者医疗保险全因费用的决定因素。
J Manag Care Pharm. 2011 Oct;17(8):610-20. doi: 10.18553/jmcp.2011.17.8.610.
3
Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.预测分化型甲状腺癌相关死亡率的最佳截断年龄
PLoS One. 2015 Jun 23;10(6):e0130848. doi: 10.1371/journal.pone.0130848. eCollection 2015.
4
Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.36725例患者中乳头状甲状腺癌和滤泡状甲状腺癌生存率的比较。
Ann Otol Rhinol Laryngol. 2014 Feb;123(2):94-100. doi: 10.1177/0003489414523563.
5
Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.肿瘤大小对甲状腺癌转移疾病风险和生存的影响:对活检指南的启示。
Thyroid. 2018 Mar;28(3):295-300. doi: 10.1089/thy.2017.0526. Epub 2018 Feb 22.
6
Cost-effectiveness analysis of papillary thyroid cancer surveillance.甲状腺乳头状癌监测的成本效益分析
Cancer. 2015 Dec 1;121(23):4132-40. doi: 10.1002/cncr.29633. Epub 2015 Aug 17.
7
A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma.基于人群的分化型和髓样甲状腺癌生存因素分析。
Otolaryngol Head Neck Surg. 2003 Jan;128(1):115-23. doi: 10.1067/mhn.2003.2.
8
Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid.甲状腺低风险乳头状微小癌管理中主动监测与即刻手术的成本比较。
Endocr J. 2017 Jan 30;64(1):59-64. doi: 10.1507/endocrj.EJ16-0381. Epub 2016 Sep 22.
9
Initial attributable cost and economic burden of clinically-relevant differentiated thyroid cancer: A health care service provider perspective.临床相关分化型甲状腺癌的初始归因成本和经济负担:医疗服务提供者视角
Eur J Surg Oncol. 2015 Jun;41(6):758-65. doi: 10.1016/j.ejso.2015.01.019. Epub 2015 Jan 31.
10
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.

引用本文的文献

1
Impact of multimorbidity on household expenditure in China: evidence from the China health and retirement longitudinal study.中国多种慢性病共病对家庭支出的影响:来自中国健康与养老追踪调查的证据
BMC Public Health. 2025 Jul 26;25(1):2550. doi: 10.1186/s12889-025-23718-9.
2
Identification and Economic Evaluation of Differentiated Thyroid Cancer Care Consumption Patterns Using Sequence Analysis.基于序列分析的分化型甲状腺癌护理消费模式识别与经济评价。
Int J Public Health. 2024 Apr 19;69:1606664. doi: 10.3389/ijph.2024.1606664. eCollection 2024.
3
Drivers of Thyroid Ultrasound Use: A Retrospective Observational Study.
甲状腺超声使用的驱动因素:一项回顾性观察研究。
Endocr Pract. 2023 Dec;29(12):948-954. doi: 10.1016/j.eprac.2023.09.006. Epub 2023 Sep 16.
4
Cost-Effectiveness of Active Surveillance Compared to Early Surgery of Small Papillary Thyroid Cancer: A Retrospective Study on a Korean Population.主动监测与早期手术治疗小乳头状甲状腺癌的成本效益比较:一项针对韩国人群的回顾性研究。
J Korean Med Sci. 2023 Aug 28;38(34):e264. doi: 10.3346/jkms.2023.38.e264.
5
Consumption of health resources in older people with differentiated thyroid carcinoma: a multicenter analysis.老年人分化型甲状腺癌患者的健康资源消耗:一项多中心分析。
Endocrine. 2023 Sep;81(3):521-531. doi: 10.1007/s12020-023-03369-9. Epub 2023 Apr 27.
6
Clinical experience following implementation of routine SPECT-CT imaging following 131-iodine administration for thyroid cancer.甲状腺癌患者接受131碘治疗后实施常规SPECT-CT成像的临床经验。
Endocr Connect. 2022 May 25;11(5):e210371. doi: 10.1530/EC-21-0371.
7
The Concept of Economic Evaluation and Its Application in Thyroid Cancer Research.经济评价的概念及其在甲状腺癌研究中的应用。
Endocrinol Metab (Seoul). 2021 Aug;36(4):725-736. doi: 10.3803/EnM.2021.1164. Epub 2021 Aug 27.
8
Differentiated Thyroid Cancer: A Health Economic Review.分化型甲状腺癌:健康经济学综述。
Cancers (Basel). 2021 May 7;13(9):2253. doi: 10.3390/cancers13092253.
9
Competing Causes of Death in Older Adults with Thyroid Cancer.老年甲状腺癌患者的死亡竞争原因。
Thyroid. 2021 Sep;31(9):1359-1365. doi: 10.1089/thy.2020.0929. Epub 2021 Apr 21.
10
Impact of frailty on inpatient outcomes in thyroid cancer surgery: 10-year results from the U.S. national inpatient sample.衰弱对甲状腺癌手术住院患者结局的影响:来自美国国家住院患者样本的10年结果
J Otolaryngol Head Neck Surg. 2020 Jul 22;49(1):51. doi: 10.1186/s40463-020-00450-5.